ESR1 and hepatocellular carcinoma: Since hepatocellular carcinoma derived HepG2 cells appear to mediate ESR1 signalling through the AF-1 transactivation function, ESR1 with N-terminal truncation may have dominant negative effect in liver, regulating the trans-activity of ERα66 [27,28].